The FDA is expected to authorize the Pfizer vaccine for use in children ages 12-15 next week, a major milestone on the path to getting more Americans vaccinated.
Axios Re:Cap digs into how vaccine trials for children are different, what’s ahead this summer and whether young kids may be eligible for vaccinations before next school year with long-time drug discovery researcher and author of the blog "In The Pipeline," Derek Lowe.
